BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16901548)

  • 1. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Kolakowski S; Lazzaretto D; McCutchan JA; Ellis R
    J Neuroimmunol; 2006 Oct; 179(1-2):180-5. PubMed ID: 16901548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
    Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
    J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid.
    Letendre S; Marquie-Beck J; Singh KK; de Almeida S; Zimmerman J; Spector SA; Grant I; Ellis R;
    J Neuroimmunol; 2004 Dec; 157(1-2):193-6. PubMed ID: 15579297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
    Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
    BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
    Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
    Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
    Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
    Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
    Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
    Cinque P; Bestetti A; Marenzi R; Sala S; Gisslen M; Hagberg L; Price RW
    J Neuroimmunol; 2005 Nov; 168(1-2):154-63. PubMed ID: 16091292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.
    Zink MC; Coleman GD; Mankowski JL; Adams RJ; Tarwater PM; Fox K; Clements JE
    J Infect Dis; 2001 Oct; 184(8):1015-21. PubMed ID: 11574916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis.
    Joven J; Coll B; Tous M; Ferré N; Alonso-Villaverde C; Parra S; Camps J
    Clin Chim Acta; 2006 Jun; 368(1-2):114-9. PubMed ID: 16445900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
    McCoig C; Castrejón MM; Saavedra-Lozano J; Castaño E; Báez C; Lanier ER; Sáez-Llorens X; Ramilo O
    Pediatr Infect Dis J; 2004 Feb; 23(2):114-8. PubMed ID: 14872175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
    Chang L; Ernst T; St Hillaire C; Conant K
    Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
    Sevigny JJ; Albert SM; McDermott MP; Schifitto G; McArthur JC; Sacktor N; Conant K; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Marder K; Epstein LG
    Arch Neurol; 2007 Jan; 64(1):97-102. PubMed ID: 17210815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection.
    Harrington PR; Connell MJ; Meeker RB; Johnson PR; Swanstrom R
    J Infect Dis; 2007 Oct; 196(7):1058-67. PubMed ID: 17763329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy.
    Coll B; Alonso-Villaverde C; Parra S; Rabassa A; Martorell L; Joven J; Masana L
    HIV Med; 2006 Sep; 7(6):356-60. PubMed ID: 16903979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
    de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.
    Cepok S; von Geldern G; Nolting T; Grummel V; Srivastava R; Zhou D; Hartung HP; Adams O; Arendt G; Hemmer B
    Ann Neurol; 2007 Nov; 62(5):458-67. PubMed ID: 17703460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of MCP-1 and IL-8 in the serum and cerebrospinal fluid of a child with Miller Fisher syndrome.
    Sato S; Suzuki K; Nagao R; Kashiwagi Y; Kawashima H; Tsuyuki K; Hoshika A
    J Clin Neurosci; 2009 Dec; 16(12):1698-9. PubMed ID: 19846311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.